Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Leptin as a cardiovascular risk marker in metabolically healthy obese Hyperleptinemia in metabolically healthy obese

Full text
Author(s):
Jamar, Giovana ; Caranti, Danielle Arisa ; Cesar, Helena de Cassia ; Landi Masquio, Deborah Cristina ; Bandoni, Daniel Henrique ; Pisani, Luciana Pellegrini
Total Authors: 6
Document type: Journal article
Source: APPETITE; v. 108, p. 477-482, JAN 1 2017.
Web of Science Citations: 7
Abstract

Adipokines contribute to the inflammatory process which can lead to obesity-associated cardiometabolic complications. Metabolically healthy obese individuals seem to be protected or more resistant to develop these complications and it is intriguing why some individuals develop comorbidities and others do not. Thus, we questioned whether the differences between metabolically healthy and unhealthy obese relied on the alterations in metabolic profile, characterized by serum leptin and adiponectin. A total of 142 obese adults were divided into 2 groups - metabolically healthy obese (MHO) or unhealthy obese (MUO) - and they were evaluated for anthropometric measures, body composition, blood pressure, dietary intakes and plasma levels of leptin and adiponectin. Leptin/adiponectin ratio (L/A) was calculated. Age, BMI and blood pressure were higher in the MUO. No differences in anthropometric measurements, body composition, dietary intake and dietary quality were observed between groups. Leptin were significantly higher in the MUO (53.07 +/- 34.56 versus 36.27 +/- 24.02 ng/ml in the MHO, r < 0.04). The logistic regression analysis demonstrated that leptin was an important factor associated with not being healthy, independent of age, body weight and BMI. There were no differences between groups for adiponectin and L/A. Leptin correlated positively with body weight (r = 0.25, r < 0.05), BMI (r = 0.38, r < 0.05) and BF (r = -0.74, r < 0.05), and negatively with FFM (r = 0.74, r < 0.05). Our findings suggest that leptin is an important cardiovascular disease marker to obese population and can contribute to evaluate metabolic risks in these individuals. (C) 2016 Elsevier Ltd. All rights reserved. (AU)

FAPESP's process: 11/51723-7 - Effects of interdisciplinary therapy on metabolic syndrome control in obese adults and its relationship with pro and anti inflammatory adipocytes
Grantee:Danielle Arisa Caranti
Support Opportunities: Regular Research Grants